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Abstract
Background: Recent studies have suggested that periodontal disease increases the risk of atherothrombotic disease.
Atherosclerosis has been characterized as a chronic inflammatory response to cholesterol deposition in the arteries.
Although several studies have suggested that certain periodontopathic bacteria accelerate atherogenesis in apolipoprotein
E-deficient mice, the mechanistic link between cholesterol accumulation and periodontal infection-induced inflammation is
largely unknown.
Methodology/Principal Findings: We orally infected C57BL/6 and C57BL/6.KOR-Apoe
shl (B6.Apoeshl) mice with
Porphyromonas gingivalis, which is a representative periodontopathic bacterium, and evaluated atherogenesis, gene
expression in the aorta and liver and systemic inflammatory and lipid profiles in the blood. Furthermore, the effect of
lipopolysaccharide (LPS) from P. gingivalis on cholesterol transport and the related gene expression was examined in
peritoneal macrophages. Alveolar bone resorption and elevation of systemic inflammatory responses were induced in both
strains. Despite early changes in the expression of key genes involved in cholesterol turnover, such as liver X receptor and
ATP-binding cassette A1, serum lipid profiles did not change with short-term infection. Long-term infection was associated
with a reduction in serum high-density lipoprotein (HDL) cholesterol but not with the development of atherosclerotic
lesions in wild-type mice. In B6.Apoeshl mice, long-term infection resulted in the elevation of very low-density lipoprotein
(VLDL), LDL and total cholesterols in addition to the reduction of HDL cholesterol. This shift in the lipid profile was
concomitant with a significant increase in atherosclerotic lesions. Stimulation with P. gingivalis LPS induced the change of
cholesterol transport via targeting the expression of LDL receptor-related genes and resulted in the disturbance of
regulatory mechanisms of the cholesterol level in macrophages.
Conclusions/Significance: Periodontal infection itself does not cause atherosclerosis, but it accelerates it by inducing
systemic inflammation and deteriorating lipid metabolism, particularly when underlying hyperlidemia or susceptibility to
hyperlipidemia exists, and it may contribute to the development of coronary heart disease.
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Introduction
Coronary heart disease (CHD) is the leading cause of death in
Japan and other developed countries. The major pathway
underlying CHD pathology is atherosclerosis. Several risk factors
for atherosclerosis have been identified, including smoking,
hypertension, hyperglycemia, hypercholesterolemia and genetic
factors. However, atherosclerosis can develop in the absence of
these classic risk factors [1]. Recent epidemiological studies have
suggested a link between atherosclerosis and infection/inflamma-
tion. Associations have been reported with Chlamydia pneumoniae,
Helicobacter pylori, and cytomegalovirus [2,3], as well as with dental
infections, particularly those associated with periodontitis [4,5].
Periodontitis is a chronic infectious disease initiated by a
group of periodontopathic bacteria, such as Porphyromonas gingivalis.
Periodontitis destroys the tooth-supporting tissues and leads to
tooth loss if not adequately treated. Of the several hypotheses
proposed to account for the effect of chronic infections on the
development of atherosclerosis [6], one—the induction of low-
grade systemic inflammation by periodontal infection—is partic-
ularly important. In fact, case-control and intervention studies
[7,8] have clearly demonstrated that high-sensitivity C-reactive
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cases of periodontitis and that successful treatment of periodontitis
decreases the levels of both mediators. However, despite inferential
evidence of an association between periodontitis and CHD, no
precise underlying mechanism linking these two diseases has been
elucidated.
Several animal studies have assessed the effects of period-
ontopathic bacterial infection on atherogenesis and documented
the formation of atheromatous plaques and elevated systemic
inflammatory markers [9,10,11]. Though, there are several points
to consider before these findings can be extrapolated to link
human periodontitis to atherosclerosis. First, intravenous inocula-
tion with bacteria, rather than the natural route of human
periodontitis (i.e., via oral tissues), was used in some experiments.
Although transient bacteremia is common in association with the
manipulation of the teeth and periodontal tissues, the magnitude
of bacteremia resulting from a dental procedure is relatively low
(,10
4 colony-forming units (CFUs) of bacteria per milliliter) [12].
Moreover, there is no information about the relationship between
the severity and extent of the disease and the magnitude of
bacteremia. Therefore, the findings observed with direct inocula-
tion of bacteria may not reflect the effects of naturally occurring
periodontitis. Second, most studies used apolipoprotein E (ApoE)-
deficient mice that spontaneously develop hyperlipidemia, which is
a well-characterized risk factor for atherosclerosis. In patients with
periodontitis, total cholesterol and low-density lipoprotein (LDL)
cholesterol levels were increased and high-density lipoprotein
(HDL) cholesterol levels were decreased compared to those
in healthy subjects [13,14,15]. Therefore, it is reasonable to
investigate the mechanism by which periodontal infection may
affect and modify existing risk factors. However, the ways in
which periodontal infection affects tissues and organs related to
atherogenesis have not been elucidated, primarily because of the
limitations of the experimental design described above and the use
of short-term infection models rather than chronic infection
models.
Here, we compared short-term and long-term infections in
normocholesterolemic and hyperlipidemic mice. We found that
oral inoculation of P. gingivalis affected the gene expression profiles
in the aorta and liver, irrespective of abnormalities in the serum
lipid profile. Additionally, infection accelerated the development of
atheromatous plaques, and the serum lipid profile became more
proatherogenic in the presence of preexisting hyperlipidemia.
Results
Alveolar bone loss due to oral Infection with P. gingivalis
Gross visual inspection of P. gingivalis-infected and sham-infected
wild-type mice under a stereoscopic microscope (Fig. 1A–D)
revealed the alveolar bone pathology. The distance between the
cement-enamel junction (CEJ) and the alveolar bone crest (ABC)
in the mandibular molars (measured by micro-CT) was signifi-
cantly different between the infected mice and the control mice.
P. gingivalis infection significantly increased the distance between
the CEJ and the ABC in the interdental region (P,0.005
compared to sham-infected mice; Fig. 1E). The effect of P.
gingivalis infection tended to be greater in B6.Apoeshl mice
compared wild-type mice (P,0.01).
Systemic response to oral Infection with P. gingivalis
Oral infection with P. gingivalis induced a significant elevation in
serum IL-6 levels during short-term infection, regardless of
whether hyperlipidemia was present (Fig. 2A). During short-term
infection, serum amyloid A (SAA) was increased in infected mice
compared with those subjected to sham infection, but this
difference did not reach a statistically significant level. Further
elevation of IL-6 and SAA was observed during long-term
infection, and significant differences were observed in both wild-
type and B6.Apoeshl mice (Fig. 2B). The serum levels of
P. gingivalis W83-specific IgG were significantly greater (P,0.01)
in P. gingivalis-infected mice compared with sham-infected mice
after short-term infection. In sham-infected mice, no production of
antibodies against P. gingivalis was observed during either short-
term or long-term infection periods. However, the infection did
induce significantly greater antibody production during short-term
infection. Further elevation of antibody levels was observed in
response to long-term infection (Fig. 2C). There was no diffe-
rence in antibody production observed between wild-type and
B6.Apoeshl mice.
Deterioration of the serum lipid profile id associated with
the infection period
In both mouse strains, oral infection with P. gingivalis had no
significant effect on the serum lipid profile during short-term
infection. In wild-type mice, only HDL cholesterol levels were
decreased by long-term infection. In contrast, all cholesterol levels
shifted toward atherogenic levels during long-term P. gingivalis
infection in B6.Apoeshl mice. Total and LDL cholesterol levels
were elevated and HDL cholesterol levels were decreased in
P. gingivalis-infected mice compared with sham-infected mice
(Table 1).
An increase in atherosclerosis is associated with
P. gingivalis infection in B6.Apoeshl mice but not in wild-
type mice
Analysis of aortic atherosclerosis demonstrated a significant
increase in lesion area during the experimental period in the
absence of infection in B6.Apoeshl mice, but not wild-type mice
(short-term infection vs. long-term infection in sham-infected
mice). P. gingivalis infection further increased the lesion size during
each infection period, and atherosclerotic plaques comprised
.40% of the total vessel area (Fig. 3B). A similar effect on the
response to infection was observed in the aortic sinus lesion
volume (Fig. 3C). Conversely, no apparent lesions were observed
at any point during the experimental period in wild-type mice.
Changes in atherogenicity-related gene expression
profiles in aortic tissue are associated with the infection
period
Oral infection with P. gingivalis significantly increased the
expression of Toll-like receptor (TLR) 2 (Fig. 4A) and TLR4
(Fig. 4B) in infected mice compared with sham-infected mice,
regardless of whether hyperlipidemia was present. In wild-type
mice, a longer bacterial burden induced a further elevation in gene
expression, whereas the difference between sham-infected and
P. gingivalis-infected mice was smaller in long-term infected
B6.Apoeshl mice.
Chemokine (C-C motif) ligand 2 (Ccl2) and early growth
response-1 (Egr1), both of which are vascular inflammation-related
genes, were also significantly up-regulated in the aortic tissues of
P. gingivalis-infected mice relative to sham-infected mice (Fig. 4C
and 4D). There was no difference in the Egr1 expression pattern
either between short-term infection and long-term infection or
between wild-type and B6.Apoeshl mice. The duration of the
infection period did not affect Ccl2 expression in sham-infected
mice, and P. gingivalis infection consistently induced the up-
regulation of gene expression.
Periodontal Infection and Atherogenesis in mice
PLoS ONE | www.plosone.org 2 May 2011 | Volume 6 | Issue 5 | e20240Figure 1. Determination of alveolar bone loss (A–D). Three-dimensional (A and B) and two-dimensional (C and D) microcomputed tomography
images of representative samples from sham-infected mice (A and C) and infected mice (B and D) are presented. The infected group (A) showed an
increase in the distance from the cement-enamel junction (CEJ) to the alveolar bone crest compared with the sham-infected group (B). Two-
dimensional micro-CT sections for the infected group (C) but not the sham-infected group (D) showed alveolar bone loss at the bifurcation.
Periodontal Infection and Atherogenesis in mice
PLoS ONE | www.plosone.org 3 May 2011 | Volume 6 | Issue 5 | e20240Because of the importance of lipid metabolism in atherogenesis
and the involvement of infection and inflammation in lipid
metabolism, the gene expression levels of several cholesterol
transport molecules liver X receptors (LXR) a, band ATP-binding
cassette A1 (ABCA1) were examined. Both Lxra and Lxrb were
down-regulated during short-term infection, and further down-
regulation was observed during long-term infection in wild-type
mice (Figs. 4E and 4F). In B6.Apoeshl mice, Lxra showed changes
similar to those in wild-type mice, whereas Lxrb did not show any
difference following infection. Abca1 was down-regulated in
P. gingivalis-infected mice, with a greater reduction being observed
during long-term infection. There was no difference in Abca1
expression between wild-type and B6.Apoeshl mice (Fig. 4G).
Changes in atherogenicity-related gene expression
profiles intheliverareassociated with theinfectionperiod
The expression levels of the inflammation-related markers
Saa1/2 and Il6 were significantly up-regulated during P. gingivalis
infection (Figs. 5A and 5B). The expression pattern showed
differences between wild-type and B6.Apoeshl mice. Long-term
infection tended to produce enhanced up-regulation of Saa in wild-
type mice, whereas the difference in gene expression was smaller
between sham-infected and P. gingivalis-infected B6.Apoeshl mice
during long-term infection. No such difference was observed for
Il6 expression. The lipid metabolism-related genes Lxra and
Lxrbwere down-regulated during short-term infection and further
down-regulated under long-term infection, regardless of whether
hyperlipidemia was present (Figs. 5C and 5D). The gene
expression profile of Abca1 showed a trend similar to that of the
Lxrs, but a significant reduction was only observed during long-
term infection (Fig. 5E). In addition, LDL receptor (Ldlr) and
inducible degrader of the LDL receptor (Idol), another LXR target
gene, were analyzed. The expression of Ldlr tended to be lower in
P. gingivalis-infected mice compared with sham-infected mice
(Fig. 5F). Consistent with Lxrs expressions, Idol expression was also
decreased in P. gingivalis-infected mice compared with sham-
infected mice. The change was greater during long-term infection
in both wild-type and B6.Apoeshl mice (Fig. 5G).
In contrast to the Lxrs and Abca1, a marked difference in
hydroxymethylglutaryl-coenzyme A reductase (Hmgcr) expression
was observed between wild-type and B6.Apoeshl mice. Infection
with P. gingivalis significantly increased the expression of Hmgcr as
the bacterial burden in wild-type mice increased, while there was
no change in the expression levels of this gene in B6.Apoeshl mice
(Fig. 5H). A significant down-regulation was also observed in
Adipor2, which is another antiatherogenic molecule (Fig. 5I).
Because triglyceride levels were significantly down-regulated
during P. gingivalis infection, particularly during long-term
infection, the expression levels of genes critical for the regulation
of triglyceride synthesis were analyzed. Both fatty acid synthase
(Fas) and sterol regulatory element-binding protein 1c (Srebf1 in
mice) expression levels were significantly down-regulated during
long-term infection but not during short-term infection in wild-
type mice (Figs. 5J and 5K). In B6.Apoeshl mice, Fas expression
was significantly lower in infected mice compared to sham-infected
mice, regardless of the length of the infection period. Srebf1
expression levels were significantly down-regulated only during
long-term infection in this strain of mice.
TLR ligands induce phosphorylation of IRF3 in
macrophages
As shown in Fig. 6, the TLR4 ligand E. coli LPS and TLR2
ligand Pam3C SK4 clearly induced the phosphorylation of IRF3
in macrophages. P. gingivalis LPS, which is known to act as an
agonist for both TLR2 and TLR4, also induced IRF3 phosphor-
ylation, although the activity of P. gingivalis LPS was much less
potent than that of E. coli LPS.
Effects of P. gingivalis and E. coli LPS on cholesterol
uptake and efflux from macrophages
Oral infection with P. gingivalis down-regulated the expression of
the Lxrs and Abca1 in both strains of mice. However, in contrast to
the progression of the atherosclerotic lesions in B6.Apoeshl mice,
no development of such lesions was observed in wild-type mice.
These results suggested that either cholesterol efflux may be much
more impaired by the infection in B6.Apoeshl mice than wild-type
mice. Alternatively cholesterol efflux may be similar between wild-
type and B6.Apoeshl mice, but cholesterol uptake may be higher
in B6.Apoeshl mice. This would result in increased cholesterol
accumulation and lesion progression. To distinguish between these
two hypotheses, the effect of LPS treatment on cholesterol efflux
by peritoneal macrophages was quantified in both strains of mice.
We found that the apoA1-dependent cholesterol efflux induced by
GW3965, a synthetic LXR agonist, was significantly inhibited by
LPS treatment. The effect of GW3965 and inhibitory effect of LPS
on GW3965-induced apoA1-dependent cholesterol efflux were
similar between wild-type mice and B6.Apoeshl mice (Fig. 7A).
Basal cholesterol uptake of B6.Apoeshl macrophages was much
higher compared to that of wild-type macrophages. LPS treatment
in the absence of GW3965 significantly increased cholesterol
uptake in both wild-type macrophage and B6.Apoeshl macro-
phage (Fig. 7B). These results suggested that increased atheroscle-
rotic lesions may be due to the increased uptake of cholesterol into
B6.Aoeshl macrophages compared with wild-type macrophages,
rather than differences in cholesterol efflux. The differences of
these cellular characteristics were further manifested by the LPS
stimulation.
Effects of P. gingivalis and E. coli LPS on LDLR expression
in macrophages
The gene expression of LDLR in B6.Apoeshl macrophages was
lower than that in wild-type macrophages and stimulation with P.
gingivalis LPS and E. coli LPS increased the gene expression in both
strains of mice. Although GW3965 suppressed the Ldlr gene
expression, either LPS abrogated the effect of GW3965. In
contrast to the Ldlr, the gene expression of Idol was higher in
B6.Apoeshl macrophages compared with wild-type macrophages.
While GW3965 increased the Idol expression in macrophages of
both strains of mice, LPS suppressed the effect of GW3965
(Fig. 8A).
Culture in the sterol-depletion medium strongly induced LDLR
protein expression in the macrophage and the addition of
GW3965 potently decreased LDLR protein levels in macrophages.
P. gingivalis LPS stimulation not only markedly attenuated the
suppressive activity of GW3965 on the LDLR expression but also
up-regulated the LDLR protein expression in B6.Apoeshl mice.
Numerical analysis of alveolar bone loss between the control group and the infected group (E; N=10 in each group) was performed. The distance
between the cement-enamel junction and alveolar bone crest in each tooth root was determined from three-dimensional micro-CT images using
image visualization software. Box plots present medians and the 25th and 75th percentiles as boxes and the 10th and 90th percentiles as whiskers.
Significant differences were observed between the infected group and the sham-infected group (* P,0.01; ** P,0.001, Mann-Whitney U-test).
doi:10.1371/journal.pone.0020240.g001
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(Fig. 8B).
Discussion
In both wild-type and B6.Apoeshl mice, oral infection with
P. gingivalis induced alveolar bone resorption, which is a
characteristic feature of chronic periodontitis. Both strains of mice
also showed elevated levels of serum antibodies against this
bacterium, indicating a systemic immune response. Because
periodontal tissue destruction is stimulated by inflammatory
mediators, rather than by the bacteria themselves [16], the
alterations in gene expression levels, the serum lipid profile and
serum inflammatory mediators observed in this study could be a
consequence of oral infection with P. gingivalis. Despite the various
systemic effects of oral infection in wild-type mice, the infection did
Figure 2. Effects of oral infection with P. gingivalis on serum levels of interleukin (IL)-6 (A), serum amyloid A (SAA; B), and anti-P.
gingivalis antibody (C; N=5 in each group). All experiments were performed in triplicate wells for each condition and repeated at least twice.
Representative data are shown. Box plots present medians and the 25th and 75th percentiles as boxes and the 10th and 90th percentiles as whiskers.
Significant differences were observed between the infected group and the sham-infected group (* P,0.05; ** P,0.01, Mann-Whitney U-test).
doi:10.1371/journal.pone.0020240.g002
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expression profiles in the aorta and liver were consistent with
proatherogenic profiles. These results are in agreement with the
findings related to the effects of other infectious agents, such as C.
pneumonia, on atherogenesis in mice. However, C. pneumonia
inoculation in wild-type mice fed a high-fat diet accelerated
hypercholesterolemia-induced atherosclerosis [17]. This suggests
that infection may play a synergistic role with other preexisting
factors, such as hyperlipidemia, to result in the development of
atherosclerosis. Therefore, it is important to clarify whether P.
gingivalis infection has the same effects as C. pneumonia. In this
context, previous studies have examined the role of periodontal
infection using ApoE-deficient mice [9,10]. These studies
demonstrated that either oral or intravenous P. gingivalis infection
accelerated atherosclerosis and raised the levels of systemic
inflammatory markers. However, the infection period in these
studies was relatively short (3 weeks), and there was no information
provided about whether long-term infection mimicked human
chronic periodontitis. Furthermore, the ways in which oral
infection affects the function of the aorta and liver, which are
the organs most relevant to atherogenesis, are unknown.
Our analysis of gene expression levels in the aorta provided new
insights into both the mechanisms linking periodontal infection
with atherosclerosis and the role of hyperlipidemia in the immune
response of B6.Apoeshl mice to P. gingivalis infection. During short-
term infection, aortic expression of both Tlr2 and Tlr4 was
significantly up-regulated. However, the stimulatory effect of P.
gingivalis oral infection was attenuated during long-term infection.
Because such attenuation is not seen in wild-type mice, in which
the expression of Tlr2 and Tlr4 was further elevated after long-
term infection compared with short-term infection, the deletion of
the ApoE gene and/or the resulting hyperlipidemia may have
affected the endothelial response. Likewise, the expression of Egr1
and Ccl2 was significantly enhanced in B6.Apoeshl mice but this
effect was less pronounced than in wild-type mice. Because the
expression of both Egr1 and Ccl2 is positively regulated by IL-6 in
endothelial cells [18], increased serum IL-6 levels in B6.Apoeshl
mice compared with wild-type mice would be expected to enhance
the transcription of these molecules. Contrary to this assumption,
IL-6 did not up-regulate these molecules. These results again
suggest that abnormal lipid metabolism may have affected
inflammatory responses in endothelial cells. The lipid metabo-
lism–inflammatory response relationship was further highlighted
by the observation of alveolar bone resorption. The effect of
P. gingivalis infection tended to be greater in B6.Apoeshl mice than
in wild-type mice. Further studies should be directed at
understanding the role of lipid metabolism during the inflamma-
tory response in blood vessels.
Additionally, infection and subsequent inflammation affected
lipid metabolism-related gene expression. While the observed
changes in Lxra and Abca1 expression were similar between wild-
type and B6.Apoeshl mice with both short-term and long-term
infections, Lxrb gene expression was not affected by oral infection
with P. gingivalis in B6.Apoeshl mice.
LXRs have been identified as central regulators of lipid
homeostasis. LXRa is expressed primarily in the liver, intestine,
adipose tissue, and macrophages, whereas LXRb is expressed in
many cell types. Endothelial cells also express functional LXRs,
and treatment with LXR agonists can up-regulate ABC trans-
porters. This result suggests that LXRs have an antiatherogenic
effect in endothelial cells [19,20]. A number of studies have
demonstrated that ABCA1 is an efficient exporter of cholesterol
from macrophages and other cells, a major determinant of plasma
HDL cholesterol levels and a potent cardioprotective factor [21].
The concomitant reduction of Lxra and Abca1 seen in the livers of
infected mice suggests that LXRs are functionally affected by oral
Table 1. Serum lipid profile associated with infection period in wild-type and B6.Apoeshl mice.
Wild-type
Short-term Long-term
Sham-infected Infected P-value Sham-infected Infected P-value
Total 102.0564.73 103.0164.70 0.841 100.3166.99 99.0663.72 0.841
CM 0.5860.26 0.3160.17 0.151 0.5660.23 0.5560.24 0.917
VLDL 8.0962.82 6.6761.08 0.421 8.9462.12 9.8363.37 1
LDL 12.7261.51 11.8860.97 0.309 11.5462.37 11.8862.17 0.548
HDL 80.6666.12 86.5365.66 0.222 89.8161.71 84.8862.53 0.008
TG 76.79632.59 47.37621.04 0.151 20.4365.21 12.4163.05 0.016
B6.Apoeshl
Short-term Long-term
Sham-infected Infected P-value Sham-infected Infected P-value
Total 750.266157.93 775.516165.26 1 614.29647.19 756.18633.93 0.008
CM 43.3365.11 35.3162.35 0.056 41.2163.91 35.6762.67 0.056
VLDL 458.716111.32 479.666143.16 1 398.89653.60 493.64645.21 0.032
LDL 249.38646.71 252.22634.07 1 179.09629.93 255.51627.64 0.016
HDL 34.8367.73 34.2968.24 0.841 38.3164.34 23.3561.81 0.008
TG 45.21641.60 59.04626.80 0.548 67.8168.30 38.21610.62 0.008
Values are indicated as mg/dL.
CM indicates chylomicron; VLDL, very low density lipoprotein; LDL, low density lipoprotein; HDL, high density lipoprotein.
N=5 in each group.
doi:10.1371/journal.pone.0020240.t001
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PLoS ONE | www.plosone.org 6 May 2011 | Volume 6 | Issue 5 | e20240Figure 3. Effects of oral infection with P. gingivalis on aortic atherosclerosis in wild-type and B6.Apoeshl mice. (A) Representative aortas
from wild-type and B6.Apoeshl mice are depicted. (B) Aortic atherosclerosis expressed as a percentage of the total area (N=8 in each group). Box
plots present medians and the 25th and 75th percentiles as boxes and the 10th and 90th percentiles as whiskers. Significant differences were
observed between the infected group and the sham-infected group (* P,0.01, Mann-Whitney U-test). (C) Representative aortic sinus cross sections
from wild-type and B6.Apoeshl mice. Original magnifications, 406.
doi:10.1371/journal.pone.0020240.g003
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TLR signaling. Castillo et al. [22] demonstrated that activation of
TLR3 and TLR4 by microbial ligands blocks the induction of
LXR target genes, including Abca1, in cultured macrophages and
aortic tissues in vivo. Crosstalk between LXR and TLR signaling is
mediated by interferon regulatory factor 3 (IRF3), a specific
effector of TLR3/4 that inhibits the transcriptional activity of
LXR. P. gingivalis contains diverse TLR ligands, including LPS,
lipoproteins, and CpG DNA, which are recognized by TLR4,
TLR2, and TLR9, respectively. Although the agonistic activity of
P. gingivalis LPS is weaker than E. coli LPS [23], we found that
P. gingivalis LPS could also induce phosphorylation of IRF3 in
macrophages, albeit to a lesser extent than E. coli LPS (Fig. 6).
Therefore, TLR signaling-mediated IRF3 activation may be a
mechanism for the down-regulation of Lxr and Abca1.
The functional effect of the change in Lxrs and Abca1 expression
levels on the shift in serum lipoproteins (particularly HDL
cholesterol) was confirmed by the inhibition of cholesterol efflux
by P. gingivalis LPS and E. coli LPS in peritoneal macrophages.
GW3965-induced apoA1-dependent cholesterol efflux was com-
pletely abolished by stimulation with LPS. However, the rate of
basal and GW3965-induced cholesterol efflux was lower in
B6.Apoeshl mice compared with wild-type mice. On the other
hand, cholesterol uptake was higher in B6.Apoeshl mice compared
to wild-type mice and the uptake was enhanced by the LPS
stimulation in both strains of mice.
Plasma cholesterol level is regulated by the LDLR and the
expression of the LDLR is regulated at transcriptional and post
translational levels. Recently, Zelcer et al. [24] found that LDLR
expression is controlled by the LXR-Idol axis where LXR induces
Idol, an E3 ubiquitin ligase that triggers LDLR degradation. Given
that Lxrs are down-regulated in the P. gingivalis-infected mice, it is
probable that Idol expression is also suppressed in the infected mice
compared to sham-infected mice and this change may relate to up-
regulation of LDLR. In fact, the expression of the Idol gene was
significantlylower in the liver of the infected mice and the change was
more prominent during the long-term infection in B6.Apoeshl mice.
Although the Ldlr expression tended to be lower in P. gingivalis-
infected mice compared to sham-infected mice, the difference wasnot
statistically significant. These changes may have negative effect on
Idol-mediated LDLR degradation resulting in the enhanced LDLR
expression and subsequent decrease of plasma cholesterol. However,
total and LDL cholesterols showed no change in wild-type mice but
rather elevation in B6.Apoeshlmice during the long-term infection.In
vitro stimulation of macrophages with LPS attenuated the GW3965-
mediated suppression of the LDLR expression and the effect of
P. gingivalis LPS was more potent than E. coli LPS. The reason for this
paradox is unclear. However, Li et al. [25] showed that the acute
inflammatoryresponsedecreaseLDLreceptorexpressionintheliver.
In contrast, the same inflammatory stimuli increased the LDLR
expression in macrophages. Our results are consistent with these
findings. In addition to Idol, the proprotein convertase subtilisin-like
kexin type 9 (PCSK9) is also implicated in the regulation of LDLR
expression [26]. Although we have not determined whether PCSK9
contributes significantly to LDLR degradation and how its activity is
affected by LPS, Feingold et al. [27] showed that inflammation sti-
mulates PCSK9 expression leading to increased LDLR degradation
but the underlying mechanisms remain elusive. Nevertheless, oral
infection of P. gingivalis does affect the expression of the genes that
regulate LDLR expression at protein level.
In wild-type mice, genes involved in lipid metabolism, but not
the lipid profile itself, were found to be altered by short-term
infection with P. gingivalis. By contrast, long-term infection reduced
HDL cholesterol levels. The exact reasons for the discrepancy
between gene expression levels and the lipid profile are not known.
However, because the reduction in the expression of the Abca1
gene, a rate-limiting factor in HDL biogenesis [28], was more
pronounced during long-term infection than during short-term
infection, it is possible that the suppression of Abca1 during long-
term infection was sufficiently robust to induce a decrease in HDL
cholesterol. Few effects of short-term infection with P. gingivalis on
total cholesterol and the size of the lipoproteins in plasma have
been reported [10]. Therefore, it appears that longer-term and
chronic infections are necessary to shift the plasma lipid profile
toward an atherogenic state, despite the observation of proathero-
genic changes in gene expression during short-term infection.
In addition to its effects on HDL cholesterol, P. gingivalis infection
induced a significant down-regulation of serum triglycerides during
long-term infection. Fas and Srebf1, which are genes involved in the
regulation of triglyceride synthesis, were also down-regulated.
Enzymes involved in triglyceride synthesis are transcriptionally
regulated by SREBP-1c [29] and LXRs [30] in the liver. LXRs are
also important regulators of FAS [31]. The conversion of glucose
into triglycerides is nutritionally regulated, and both insulin and
glucose signaling pathways are involved. Given that LXRs are key
regulators of insulin and glucose signaling pathways that were
down-regulated in infected mice of both strains, the resulting down-
regulation of Fas and Srebf1 and subsequent decrease in serum
triglycerides could be due to P. gingivalis infection.
Severe periodontitis has been associated with a modest decrease
in HDL and LDL cholesterol levels and a more robust increase in
plasma triglycerides [32,33]. Although the effects of periodontal
infection on the lipid profile of long-term infected B6.Apoeshl mice
are slightly different from those seen in human periodontitis,
particularly with regard to triglycerides, it is clear that infection
does affect lipid metabolism. However, further studies are
necessary to clarify the relationship between chronic infection
and lipid metabolism. Nevertheless, the systemic inflammation
induced by P. gingivalis oral infection is associated with a shift to a
proatherogenic serum lipid profile that leads to elevated LDL
cholesterol and decreased HDL cholesterol levels [34].
In summary, P. gingivalis is a representative periodontopathic
bacterium that does not have the ability to induce atherosclerosis
but can accelerate the progression of atherosclerosis by affecting
blood vessel and liver function when hyperlipidemia is present.
The results of the present study provide a potential mechanism for
this bacterium’s contribution to atherogenesis and shed light on
the underlying mechanism by which periodontitis affects athero-
sclerosis and subsequent CHD in humans.
Materials and Methods
Reagents
GW3965 hydrochloride, Sandoz 58-035, Apolipoprotein A-1,
simvastatin sodium salt, mevalonic acid and lipoprotein-deficient
fetal bovine serum (LPDS) were purchased from Sigma-Aldrich
Figure 4. Comparison of relative gene expression levels in the aorta between the control group and the infected group or between
the short-term and long-term infected groups (N=5 in each group). The relative quantity of experimental mRNA was normalized to the
relative quantity of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA. The box plots present medians and the 25th and 75th percentiles
as boxes and the 10th and 90th percentiles as whiskers. (* P,0.01, Mann-Whitney U-test)
doi:10.1371/journal.pone.0020240.g004
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PLoS ONE | www.plosone.org 9 May 2011 | Volume 6 | Issue 5 | e20240Figure 5. Comparison of the relative gene expression levels in the liver between the control group and the infected groups or
between the short-term and long-term infected groups (N=5 in each group). The relative quantity of mRNA was normalized to the relative
quantity of GAPDH mRNA. The box plots present medians and the 25th and 75th percentiles as boxes and the 10th and 90th percentiles as whiskers.
(* P,0.05; ** P,0.01, Mann-Whitney U-test)
doi:10.1371/journal.pone.0020240.g005
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difluoride)-24-norcholesterol was obtained from Avanti Polar
Lipids, Inc. (Alabaster, AL). M-PER Mammalian Protein
Extraction Reagent and Pierce BCA Protein Assay kit were
obtained from Thermo Scientific (Rockford, IL). Pam3Cys-
SKKKK x 3HCl (Pam3CSK4) was purchased from EMC
microcollections (Tuebingen, Germany). Lipopolysaccharide
(LPS) from Escherichia coli O111:B4 was purchased from Sigma.
LPS from P. gingivalis 381 was kindly provided by H. Kumada and
T. Umemoto (Department of Microbiology, Kanagawa Dental
University, Yokosuka, Japan). Rabbit anti-mouse IRF3 (Santa
Cruz Biotechnology, Santa Cruz, CA), rabbit anti-mouse
phospho-IRF3 (Cell Signaling Technology, Danvers, MA), rabbit
anti-mouse GAPDH (Santa Cruz Biotechnology), peroxidase
labeled anti-rabbit antibody (GE Healthcare, Munich, Germany)
and ECL Plus Western Blotting Reagent Pack (Amersham
Biosciences, Buckinghamshire, UK) were used for western blotting
experiments.
Mice
All experiments were performed in accordance with the
Regulations and Guidelines on Scientific and Ethical Care and
Use of Laboratory Animals of the Science Council of Japan,
enforced on June 1, 2006, and approved by the Institutional
Animal Care and Use Committee at Niigata University (permit
number 39). Six-week-old male C57BL/6 mice and spontaneously
hyperlipidemic male C57BL/6.KOR -Apoe
shl (B6.Apoeshl) mice
[35,36] were obtained from Japan SLC, Inc. (Shizuoka, Japan).
The mice were maintained under specific pathogen-free condi-
tions and fed regular chow and sterile water until the
commencement of infection at 8 weeks of age.
Bacterial Cultures
P. gingivalis strain W83 was cultured in modified Gifu anaerobic
medium (GAM) broth (Nissui, Tokyo, Japan) in an anaerobic jar
(Becton Dickinson Microbiology System, Cockeysville, MD) in the
presence of an AnaeroPack
TM (Mitsubishi Gas Chemical Co. Inc.,
Tokyo, Japan) for 48 hours at 37uC. Bacterial suspensions were
prepared in phosphate-buffered saline (PBS) without Mg
2+/Ca
2+
using established growth curves and spectrophotometric analysis.
The number of CFUs was standardized by measuring optical
density (600 nm).
Oral Infection
The murine experimental periodontitis model was developed
according to Baker et al. [37] with slight modifications. The
animals received sulfamethoxazole and trimethoprim at final
concentrations of 700 mg/ml and 400 mg/ml, respectively, in
water bottles ad libitum for 10 days. This treatment was followed by
3 days without antibiotics. The experimental group was then
infected. A total of 10
9 CFU of live P. gingivalis suspended in 100 ml
of PBS with 2% carboxymethyl cellulose (Sigma-Aldrich) was
given to each mouse via a feeding needle. This suspension was
given either 10 times (short-term infection) or 42 times (long-term
infection) at 3-day intervals. The control group received the same
pretreatment and was sham infected without the P. gingivalis. Two
days after the final treatment, the mice were fasted for 16 hours,
and oral swabs were obtained and tested for the presence of P.
gingivalis as previously described [38]. Mice were then euthanized
with CO2, and their tissues were removed.
Quantification of Alveolar Bone Loss
For quantitative three-dimensional (3-D) analysis of alveolar
bone loss, mandibles were scanned by micro-computerized
tomography (micro-CT) (Skyscan 1174; Skyscan, Kontich,
Belgium). The micro-CT settings were as follows: pixel size,
102461024; slice thickness, 6 mm; magnification, 66;v o l t a g e ,
50 kV; and electrical current, 0.08 mA. The 3-D views were
constructed with the imaging software program CTan Ver.1.5.0
(SkyScan), and alveolar bone loss was analyzed with the
software program CTvol ver.1.9.4 (SkyScan). The sagittal plane
of the specimens was set parallel to the x-ray beam axis.
The distance from the distal CEJ of the first molar in the middle
of the lingual-distal root to the interdental ABC between the
first and second molars was measured in the sagittal plane
parallel to the lingual-distal root. The measurements of alveolar
bone loss in mice were performed by blinded examiners
(SM and DY).
Serum Lipoprotein, SAA, IL-6 and IgG Antibody Levels
Sera were obtained prior to euthanasia, and serum cholesterol
and triglyceride profiles were analyzed at Skylight Biotech Inc.
(Akita, Japan). Serum IL-6 and serum amyloid A (SAA) were
measured using commercial ELISA kits (Thermo Scientific and
Kamiya Biomedical, Seattle, WA, respectively). P. gingivalis-specific
IgG antibodies levels were measured by ELISA according to a
previously described method [33].
Real-time PCR
Total RNA isolated from aorta, liver tissues and macrophages
was extracted using an RNeasy Mini kit and treated with DNase I
(Qiagen, Germantown, MD) according to the manufacturer’s
instructions. Aliquots of RNA were then reverse-transcribed to
cDNA using random primers (Takara Bio Inc., Shiga, Japan) and
M-MLV reverse transcriptase (Invitrogen, Carlsbad, CA). Primers
and probes specific for real-time PCR were purchased from
Applied Biosystems (Foster City, CA). Reactions were carried out
in a 25- ml mixture in the ABI PRISM 7900HT Sequence
Detection System (Applied Biosystems) using TaqMan Gene
Expression Assays (Applied Biosystems) containing 900 nM primer
and 250 nM probe. The reactions consisted of a 10-minute
incubation at 95uC, followed by 40 cycles of a two-step
amplification procedure consisting of annealing/extension at
Figure 6. Induction of IRF3 phosphorylation in RAW 264.7
macrophages by TLR2 and TLR4 ligands. Cells were stimulated
with 1.0 mg/ml of P. gingivalis LPS, 0.1 mg/ml of E. coli LPS or 0.1 mg/ml
of Pam3CSK4 for 12 hrs. Phosphorylation of IRF3 cellular extracts was
analyzed by western blotting. Blot is a representative of three
independent experiments.
doi:10.1371/journal.pone.0020240.g006
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PRISM SDS 2.0 software (Applied Biosystems) was used to
analyze the standards and carry out the quantifications. The
relative quantity of each mRNA was normalized to the relative
quantity of glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
mRNA.
Assessment of the Atherosclerotic Lesion Area
The extent of atherosclerotic lesions in the aortic tree was
determined by en face quantification. The aorta was harvested,
opened longitudinally, fixed with 4% PFA/PBS and stained with
oil red O (Sigma-Aldrich). The stained area was analyzed using
ImageJ 1.42 q (Wayne Rasband, National Institutes of Health)
Figure 7. Lipopolysaccharide from P. gingivalis and E. coli inhibit cholesterol efflux and enhance cholesterol uptake. (A) Peritoneal
macrophages from wild-type and B6.Apoeshl mice were loaded with BODIPY-cholesterol and treated with vehicle, 1 mg/ml P. gingivalis LPS or 0.1 mg/
ml E. coli LPS in the presence or absence of 1 mM GW3965. Data are presented as apoA1-dependent cholesterol efflux. (B) Cholesterol uptake was
estimated as the total of cellular and effluxed cholesterol. The results are shown as the mean ± S.D. of three independent experiments. There were
significant differences found between the wild-type and B6.Apoeshl macrophages (unpaired t-test; 1 P,0.05) and between control and LPS-treated
macrophages in the absence (paired t-test; * P,0.05) or presence of GW3965 (paired t-test; { P,0.05).
doi:10.1371/journal.pone.0020240.g007
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PLoS ONE | www.plosone.org 12 May 2011 | Volume 6 | Issue 5 | e20240Figure 8. Lipopolysaccharide from P. gingivalis and E. coli alter the LDLR expression in macrophages. Peritoneal macrophages from wild-
type and B6.Apoeshl mice were cultured in the sterol depletion medium for 8 hours and the effect of LPS was evaluated in the presence or absence
of GW3965 following 18 hours of incubation. (A) Total RNA was extracted from the cells and gene expression of LDLR and Idol was analyzed by
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area. In addition, frozen sections of the proximal aorta were
prepared [39]. Briefly, five sections (10 mm thick) per mouse, each
separated by 100 mm, were stained with oil red O.
Western blots
For IRF-3 analysis, RAW 264.7 macrophages were seeded in a
24-well culture plate (TPP, Trasadingen, Switzerland) at a
concentration of 1610
6 cells/ml in D-MEM supplemented with
1% penicillin/streptomycin. After 12 hours of incubation, the cells
were stimulated for 30 minutes with 1 mg/ml of P. gingivalis LPS,
0.1 mg/ml of E. coli LPS or 0.1 mg/ml of Pam3CSK4 in medium.
The protein expression of LDLR was evaluated in peritoneal
macrophages obtained from wild-type and B6.Apeshl mice. The
macrophages were collected 4 days after intraperitoneal injection
of aged sterile 3% thioglycollate and cultured in a 12-well culture
plate (TPP, Trasadingen, Switzerland) at a concentration of
1610
6/well in D-MEM supplemented with 10% LPDS, 5 mM
simvastatin, and 100 mM mevalonic acid (sterol-depletion medi-
um) for 8 hours and then treated with LPS from P. gingivalis (1 mg/
ml) and E. coli (0.1 mg/ml) in the presence or absence of GW3965
(1 mM) for 18 hours.
The cultured cells were washed twice with ice-cold PBS, and the
protein was extracted using M-PER Mammalian Protein Extrac-
tion Reagent (Pierce Biotechnology) supplemented with a Halt
Protease Inhibitor Cocktail Kit (Thermo Scientific) and Halt
Phosphatase Inhibitor Cocktail (Thermo Scientific) according to
the manufacturer’s instructions. Cell debris was pelleted by
centrifugation at 12000 x g for 10 minutes at 4uC. The protein
concentration in the supernatant was determined using a Pierce
BCA Protein Assay kit (Thermo Scientific) according to the
manufacturer’s instructions.
Twelve micrograms of each sample was solubilized using SDS
sample buffer, separated by SDS-PAGE, transferred to a
polyvinylidene difluoride membrane (Immobilon-P; Millipore
Co., Bedford, MA), subjected to western blotting with each
antibody, and developed with ECL using Lumi Vision PRO
400EX (Aisin, Aichi, Japan). For reprobing of GAPDH, the
membranes were washed 3 times with wash buffer (Tris-buffered
saline containing 0.1% Tween-20 and 0.5% BSA) and subjected to
western blotting with anti-GAPDH antibody, as described above.
Cholesterol influx and efflux in macrophages
Peritoneal macrophages from wild-type and B6.Apoeshl mice
were collected 4 days after intraperitoneal injection of aged sterile
3% thioglycollate and plated in a 12-well culture plate (TPP,
Trasadingen, Switzerland) at a concentration of 1610
6/well in D-
MEM containing 5% FBS and 1% penicillin/streptomycin,
hereafter referred to as medium. Efflux assays were slightly
modified from those described by Venkateswaran et al. [40].
Adherent cells were incubated with medium supplemented with
ACAT inhibitor (58-035; 2 mg/ml) and BODIPY-cholesterol
(10 mg/ml) for 24 hrs. The labeled cells were then treated with
P. gingivalis LPS (1.0 mg/ml) or E. coli LPS (0.1 mg/ml) and/or
GW3965 for 4 hrs. After cells were washed with HBSS, ApoA1
(10 mg/ml) was added to the culture and the cells were incubated
for and additional12 hrs. Following incubation, the supernatants
were removed and the cells were dissolved using M-PER
Mammalian Protein Extraction Reagent. The labeled cholesterol
in the supernatants and cell fractions was determined using a
Versa Fluor Fluorometer (Bio-Rad, Hercules, CA) equipped with
the appropriate filters. Uptake of cholesterol in the cells was
estimated as the total of released and cellular labeled cholesterol,
whereas the ApoA1-dependent efflux of labeled cholesterol from
the cells into the medium was determined by calculating the
percentage of the total labeled cholesterol in the cells for each
condition.
Statistical Analysis
Nonparametric data were evaluated using the Mann-Whitney
U test with GraphPad Prism (GraphPad Software, Inc., La Jolla,
CA) for two-group comparisons. A probability value (P) ,0.05 was
considered statistically significant.
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